Fenofibrate Trial Aims to Prevent Worsening of Diabetic Retinopathy
A randomized trial is evaluating fenofibrate's efficacy in preventing worsening of diabetic retinopathy over 6 years.
Therapeutic Area
Therapeutic area intelligence for Diabetic Retinopathy with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
A new study is underway to evaluate the safety, tolerability, and pharmacokinetics of RO7663498 in diabetic retinopathy patients.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.